These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 23235958)
1. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system. Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958 [TBL] [Abstract][Full Text] [Related]
2. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
3. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy. Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692 [TBL] [Abstract][Full Text] [Related]
5. Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms. Greenwald RB; Pendri A; Conover C; Gilbert C; Yang R; Xia J J Med Chem; 1996 May; 39(10):1938-40. PubMed ID: 8642549 [No Abstract] [Full Text] [Related]
6. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate. Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501 [TBL] [Abstract][Full Text] [Related]
7. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery. Hu X; Hu J; Tian J; Ge Z; Zhang G; Luo K; Liu S J Am Chem Soc; 2013 Nov; 135(46):17617-29. PubMed ID: 24160840 [TBL] [Abstract][Full Text] [Related]
8. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system. Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083 [No Abstract] [Full Text] [Related]
9. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy. Lu Y; Jia D; Ma X; Liang M; Hou S; Qiu W; Gao Y; Xue P; Kang Y; Xu Z ACS Appl Mater Interfaces; 2021 Feb; 13(7):8940-8951. PubMed ID: 33565847 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin. Legigan T; Clarhaut J; Renoux B; Tranoy-Opalinski I; Monvoisin A; Berjeaud JM; Guilhot F; Papot S J Med Chem; 2012 May; 55(9):4516-20. PubMed ID: 22515366 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug. Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542 [TBL] [Abstract][Full Text] [Related]
13. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705 [TBL] [Abstract][Full Text] [Related]
14. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Conover CD; Greenwald RB; Pendri A; Shum KL Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271 [TBL] [Abstract][Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849 [TBL] [Abstract][Full Text] [Related]
16. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug. Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392 [TBL] [Abstract][Full Text] [Related]
17. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663 [TBL] [Abstract][Full Text] [Related]
18. A macromolecular prodrug strategy for combinatorial drug delivery. Li NN; Lin J; Gao D; Zhang LM J Colloid Interface Sci; 2014 Mar; 417():301-9. PubMed ID: 24407691 [TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
20. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell. Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]